Search research articles
Contact Us
Filters
Showing results (81-90 of 246) with videos related to
Page
of 25
Sort By:
Medicinal Research Reviews
|
February 13, 2019
Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
Kinsie E Arnst, Souvik Banerjee, Hao Chen, et al.
Journal of Medicinal Chemistry
|
February 24, 2023
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, et al.
Drug Development Research
|
March 21, 2014
Quinic acid derivative KZ-41 exhibits radiomitigating activity in preclinical models of radiation injury
Karin E Thompson, Kui Zeng, Christy M Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 29, 2006
Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands
Supriya A Bavadekar, Guoyi Ma, Suni M Mustafa, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2005
Synthesis and biological studies of yohimbine derivatives on human alpha2C-adrenergic receptors
Suni M Mustafa, Supriya A Bavadekar, Guoyi Ma, et al.
Journal of Cellular and Molecular Medicine
|
August 18, 2023
Next-generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma
Chuanhe Yang, Yali He, Yinan Wang, et al.
Expert Opinion on Drug Discovery
|
June 7, 2013
Novel approaches to glioma drug design and drug screening
Shivaputra A Patil, Amira Hosni-Ahmed, Terreia S Jones, et al.
Journal of Medicinal Chemistry
|
October 23, 2020
Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
Journal of Medicinal Chemistry
|
July 16, 2021
Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
Journal of Cellular and Molecular Medicine
|
February 2, 2021
Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells
Yinan Wang, Chuan He Yang, Andrew P Schultz, et al.
Page
of 25
Search research articles
Search
Showing results (81-90 of 246) with videos related to
Sort By:
Page
of 25
Medicinal Research Reviews
|
February 13, 2019
Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
Kinsie E Arnst, Souvik Banerjee, Hao Chen, et al.
Journal of Medicinal Chemistry
|
February 24, 2023
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, et al.
Drug Development Research
|
March 21, 2014
Quinic acid derivative KZ-41 exhibits radiomitigating activity in preclinical models of radiation injury
Karin E Thompson, Kui Zeng, Christy M Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 29, 2006
Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands
Supriya A Bavadekar, Guoyi Ma, Suni M Mustafa, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2005
Synthesis and biological studies of yohimbine derivatives on human alpha2C-adrenergic receptors
Suni M Mustafa, Supriya A Bavadekar, Guoyi Ma, et al.
Journal of Cellular and Molecular Medicine
|
August 18, 2023
Next-generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma
Chuanhe Yang, Yali He, Yinan Wang, et al.
Expert Opinion on Drug Discovery
|
June 7, 2013
Novel approaches to glioma drug design and drug screening
Shivaputra A Patil, Amira Hosni-Ahmed, Terreia S Jones, et al.
Journal of Medicinal Chemistry
|
October 23, 2020
Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
Journal of Medicinal Chemistry
|
July 16, 2021
Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
Journal of Cellular and Molecular Medicine
|
February 2, 2021
Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells
Yinan Wang, Chuan He Yang, Andrew P Schultz, et al.
Page
of 25